Skip to main content

Experts hesitate on weight loss ETFs amid the obesity drug boom

While weight loss drugmakers are catching a bid with investors, experts are less certain that ETFs linked to the category can achieve the same success.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.